Wenchao Hu1, Ping Feng. 1. Department of Endocrinology, General Hospital of Tianjin Medical University, 154 Anshan Street, Heping District, 300052, Tianjin, PR China.
Abstract
AIM: Chemerin, a new adipocytokine, has been suggested to be linked to obesity-induced insulin resistance and type 2 diabetes. The association of plasma chemerin levels with diabetic nephropathy, however, is unknown. Therefore, this study aims to determine whether plasma chemerin levels are associated with renal function in type 2 diabetic patients. METHODS: A total of 116 type 2 diabetic patients and 38 healthy subjects were enrolled in this study. Serum levels of chemerin were measured by enzyme-linked immunosorbent assay. RESULTS: Serum chemerin was significantly elevated in type 2 diabetic patients with macroalbuminuria compared with control subjects and diabetic patients with normoalbuminuria and microalbuminuria. No differences were found in the level of serum chemerin between diabetic patients with normoalbuminuria and microalbuminuria and control subjects. Serum chemerin was positively correlated with age, body mass index (BMI), systolic blood pressure (SBP), C-reactive protein (CRP), blood urea nitrogen (BUN), serum creatinine and serum triglycerides, and negatively correlated with creatinine clearance Stepwise regression analysis showed that creatinine clearance and serum creatinine remained significantly associated with serum chemerin. CONCLUSION: Serum chemerin levels are strongly associated with renal function in diabetic patients.
AIM: Chemerin, a new adipocytokine, has been suggested to be linked to obesity-induced insulin resistance and type 2 diabetes. The association of plasma chemerin levels with diabetic nephropathy, however, is unknown. Therefore, this study aims to determine whether plasma chemerin levels are associated with renal function in type 2 diabeticpatients. METHODS: A total of 116 type 2 diabeticpatients and 38 healthy subjects were enrolled in this study. Serum levels of chemerin were measured by enzyme-linked immunosorbent assay. RESULTS: Serum chemerin was significantly elevated in type 2 diabeticpatients with macroalbuminuria compared with control subjects and diabeticpatients with normoalbuminuria and microalbuminuria. No differences were found in the level of serum chemerin between diabeticpatients with normoalbuminuria and microalbuminuria and control subjects. Serum chemerin was positively correlated with age, body mass index (BMI), systolic blood pressure (SBP), C-reactive protein (CRP), blood ureanitrogen (BUN), serum creatinine and serum triglycerides, and negatively correlated with creatinine clearance Stepwise regression analysis showed that creatinine clearance and serum creatinine remained significantly associated with serum chemerin. CONCLUSION: Serum chemerin levels are strongly associated with renal function in diabeticpatients.
Authors: Lei Zhao; Yasuto Yamaguchi; Shadi Sharif; Xiao-Yan Du; Jason J Song; David M Lee; Lawrence D Recht; William H Robinson; John Morser; Lawrence L K Leung Journal: J Biol Chem Date: 2011-09-19 Impact factor: 5.157
Authors: Stephanie W Watts; Emma S Darios; Adam E Mullick; Hannah Garver; Thomas L Saunders; Elizabeth D Hughes; Wanda E Filipiak; Michael G Zeidler; Nichole McMullen; Christopher J Sinal; Ramya K Kumar; David J Ferland; Gregory D Fink Journal: FASEB J Date: 2018-06-15 Impact factor: 5.191
Authors: Stephanie W Watts; Anne M Dorrance; Mark E Penfold; Jillian L Rourke; Christopher J Sinal; Bridget Seitz; Timothy J Sullivan; Trevor T Charvat; Janice M Thompson; Robert Burnett; Gregory D Fink Journal: Arterioscler Thromb Vasc Biol Date: 2013-04-04 Impact factor: 8.311
Authors: David J Ferland; Emma D Flood; Hannah Garver; Steve T Yeh; Stanley Riney; Adam E Mullick; Gregory D Fink; Stephanie W Watts Journal: Physiol Genomics Date: 2019-10-07 Impact factor: 3.107
Authors: Emma S Darios; Brittany M Winner; Trevor Charvat; Antoni Krasinksi; Sreenivas Punna; Stephanie W Watts Journal: Am J Physiol Heart Circ Physiol Date: 2016-07-01 Impact factor: 4.733